Robot-assisted Hand Rehabilitation for Patients With Stroke
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03392493 |
Recruitment Status :
Completed
First Posted : January 8, 2018
Last Update Posted : December 3, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Stroke | Behavioral: Robot-assisted hand rehabilitation Behavioral: Standard treatment | Not Applicable |
Many stroke survivors suffered problems with the upper extremity, such as paresis, synergy movement, hypertonicity, jag movement, sensory deficit. An inability to use the upper extremity in daily life can lead to loss of independence with ADLs and of important occupations (eg,work, driving). For individuals with more severe paresis, the potential for recovery of upper extremity function is greatly reduced. Robotic therapy can deliver larger amounts of upper extremity movement practice for these individuals. Although the Robotic therapy appears to provide some benefit for upper extremity motor abilities and participation but is of uncertain utility compared with dose-matched conventional upper limb exercise therapies. Objective: To investigate the effects of robot-assisted hand rehabilitation with a Gloreha device on sensory, motor, and ADL ability for patients with stroke.
Materials and Methods: Thirty patients with moderate motor deficits were recruited and randomized into 2 treatment groups, AB or BA (A = 12 times of robot-assisted hand rehabilitation, B = 12 times of standard therapy) for 12 weeks of treatment (Sixty minutes a time, twice a week), 1 month of break between conditions for washout period. The performance was assessed by a blinded assessor for five times (pre-test1, post-test 1, pre-test2, post-test 2, follow up at three month). The outcome measures Fugl-Meyer Assessment-Upper Limb section(FMA-UE),Box and block test(BBT), Maximal voluntary contraction(MVC) of extensor digitorum communis(EDC), Abductor pollicis brevis(APB), Flexor digitorum(FD), Dynanometer, Semmes-Weinstein hand monofilament (SWM), Revision of the Nottingham Sensory Assessment (EmNSA) for hand evaluations, Modified Barthel Index for ADL ability. Collected data will be analyzed with ANOVA test by SPSS version 20.0, and alpha level was set at 0.05. The hypothesis are robot-assisted hand rehabilitation with a Gloreha device has positive effects on sensory, motor, hand function, and ADL ability among patients with stroke.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 25 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Intervention Model Description: | AB or BA |
Masking: | Single (Outcomes Assessor) |
Masking Description: | Single Blind (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | The Effects on Hand Function With Robot-assisted Rehabilitation for Patients With Stroke |
Actual Study Start Date : | February 1, 2018 |
Actual Primary Completion Date : | June 30, 2018 |
Actual Study Completion Date : | June 30, 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: Group A
In the phase 1 :12 training sessions of Robot-assisted hand rehabilitation(60 minutes a time, 2 times a week); In the phase 2 :12 training sessions of Standard treatment only. (60 minutes a time, 2 times a week)
|
Behavioral: Robot-assisted hand rehabilitation
Robot-assisted hand rehabilitation: 20 minute of worm-up exercise and 40 minute of robot-assisted hand exercise. Robot-assisted hand exercises include passive range of motion of hand, bilateral hands task and robot-assisted task. Behavioral: Standard treatment Standard treatment only group: 60 min standard treatment. 20 minute of worm-up exercise and 40 minute of traditional occupational therapy. Traditional occupational therapy include spasticity-reducing activity, bilateral hands activity and hand training task. |
Active Comparator: Group B
In the phase 1 :12 training sessions of Standard treatment only(60 minutes a time, 2 times a week) ; In the phase 2 :12 training sessions of Robot-assisted hand rehabilitation(60 minutes a time, 2 times a week)
|
Behavioral: Robot-assisted hand rehabilitation
Robot-assisted hand rehabilitation: 20 minute of worm-up exercise and 40 minute of robot-assisted hand exercise. Robot-assisted hand exercises include passive range of motion of hand, bilateral hands task and robot-assisted task. Behavioral: Standard treatment Standard treatment only group: 60 min standard treatment. 20 minute of worm-up exercise and 40 minute of traditional occupational therapy. Traditional occupational therapy include spasticity-reducing activity, bilateral hands activity and hand training task. |
- Fugl-Meyer Assessment:Upper Limb section [ Time Frame: Change from baseline to 6 weeks, 10 weeks,16weeks, follow up at three month ]Upper Limb motor function
- Box and block test [ Time Frame: Change from baseline to 6 weeks, 10 weeks,16weeks, follow up at three month ]Upper Limb motor function
- EMG: record maximal voluntary contraction(MVC) of brachioradialis, extensor carpi, abductor pollicis longus [ Time Frame: Change from baseline to 6 weeks, 10 weeks,16weeks, follow up at three month ]Grip strength
- Dynanometer [ Time Frame: Change from baseline to 6 weeks, 10 weeks,16weeks, follow up at three month ]Grip strength
- Semmes-Weinstein hand monofilament [ Time Frame: Change from baseline to 6 weeks, 10 weeks,16weeks, follow up at three month ]Light touch
- Revision of the Nottingham Sensory Assessment [ Time Frame: Change from baseline to 6 weeks, 10 weeks,16weeks, follow up at three month ]Proprioception
- Modified barthel index [ Time Frame: Change from baseline to 6 weeks, 10 weeks,16weeks, follow up at three month ]Activity of daily live ability

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- First stroke with hemiplegia
- Chronicity > 3 months
- Could understand the instructions
- Brunnstrom stageⅡ-Ⅴ
- Sensory impairment (Revision of the Nottingham Sensory Assessment-Tatile< 2; Kinaesthetic < 3)
- Modified Ashworth Scale < 3
Exclusion Criteria:
- Age younger than 20 and older than75 years
- Individuals with visual or auditory impairment who couldn't see or hear the feedback from the device clearly
- Individuals with other medical symptoms that can affect movement

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03392493
Taiwan | |
Department of Physical Medicine and Rehabilitation, Shuang Ho Hospital, Taipei Medical University | |
Taipei, Taiwan |
Study Chair: | Jui chi Lin, master | Taipei Medical University, Taiwan, R.O.C. |
Responsible Party: | Taipei Medical University Shuang Ho Hospital |
ClinicalTrials.gov Identifier: | NCT03392493 |
Other Study ID Numbers: |
TMU-JIRB N201704068 |
First Posted: | January 8, 2018 Key Record Dates |
Last Update Posted: | December 3, 2018 |
Last Verified: | June 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Stroke Robotic rehabilitation Hand function Activities of Daily Living |
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |